Dr Zhong Shuyi is a Post-doctoral Fellow at the School of Public Health, specialising in epidemiology and biostatistics with a focus on influenza vaccine immunogenicity and effectiveness. She obtained her Ph.D. from the University of Hong Kong in 2025, where her research investigated repeated influenza vaccination effects and immune correlates of protection. Prior to her doctoral studies, she earned both her Master of Medicine and Bachelor of Medicine from Sun Yat-sen University.

With expertise in clinical trial coordination, advanced data analysis, and laboratory techniques, Dr Zhong’s current research examines the cost-effectiveness of influenza vaccination strategies and models antibody dynamics following repeated immunisation. Her work has been published in high-impact journals, contributing to evidence-based vaccine policy and infectious disease prevention. As a dedicated researcher, she combines methodological rigor with public health applications to optimise vaccination strategies and improve population health outcomes.

1. Zhong S, Thompson MG, Cowling BJ. The Potential for Twice-Annual Influenza Vaccination to Reduce Disease Burden. Influenza Other Respir Viruses. 2025 Mar;19(3):e70052. doi: 10.1111/irv.70052. [IF: 4.2, Ranked 25 out of 137 under the category of “Infectious Diseases”]
2. Zhong S, Ng TWY, Skowronski DM, Iuliano AD, Leung NHL, Perera RAPM, Ho F, Fang VJ, Tam YH, Ip DKM, Havers FG, Fry AM, Aziz-Baumgartner E, Barr IG, Peiris M, Thompson MG, Cowling BJ. Influenza A(H3N2) Antibody Responses to Standard-Dose Versus Enhanced Influenza Vaccine Immunogenicity in Older Adults and Prior Season's Vaccine Status. J Infect Dis. 2024 May 15;229(5):1451-1459. doi: 10.1093/infdis/jiad497. [IF: 4.5, Ranked 19 out of 137 under the category of “Infectious Diseases”]
3. Zhong JC, Zhong S, Touyon L, Ho F, Au NYM, Cheng SMS, Ip DKM, Peiris M, Martin ET, Cobey S, Wong SS, Leung NHL, Cowling BJ. Repeat influenza vaccination effects in 2021/22 and 2022/23 in a community-based cohort in Hong Kong. J Infect Dis. 2026 Jan 28:jiag051. doi: 10.1093/infdis/jiag051. [IF: 4.5, Ranked 19 out of 137 under the category of “Infectious Diseases”]
4. Cowling BJ, Zhong S. Repeat vaccination and influenza vaccine effectiveness. Lancet Respir Med. 2023 Jan;11(1):2-3. doi: 10.1016/S2213-2600(22)00305-8. [IF: 32.8, Ranked 1 out of 108 under the category of “Respiratory System”]
5. Taaffe J, Zhong S, Goldin S, Rawlings KS, Cowling BJ, Zhang W. An overview of influenza H5 vaccines. Lancet Respir Med. 2025 Apr;13(4):e20-e21. doi: 10.1016/S2213-2600(25)00052-9. [IF: 32.8, Ranked 1 out of 108 under the category of “Respiratory System”]
6. Zhong S, Wei H, Li M, Cheng Y, Wen S, Wang D, Shu Y. Single Nucleotide Polymorphisms in the Human Leukocyte Antigen Region Are Associated With Hemagglutination Inhibition Antibody Response to Influenza Vaccine. Front Genet. 2022 Feb 7;13:790914. doi: 10.3389/fgene.2022.790914. [IF: 2.8, Ranked 79 out of 191 under the category of “Genetics & Heredity”]
7. Wen S, Wei H, Liao Q, Li M, Zhong S, Cheng Y, Huang W, Wang D, Shu Y. Identification of Two Novel Candidate Genetic Variants Associated With the Responsiveness to Influenza Vaccination. Front Immunol. 2021 Jul 1;12:664024. doi: 10.3389/fimmu.2021.664024. [IF: 5.9, Ranked 32 out of 183 under the category of “Immunology”]
8. Liu D, Maimaitijiang R, Gu J, Zhong S, Zhou M, Wu Z, Luo A, Lu C, Hao Y. Using the Unified Theory of Acceptance and Use of Technology (UTAUT) to Investigate the Intention to Use Physical Activity Apps: Cross-Sectional Survey. JMIR Mhealth Uhealth. 2019 Aug 22;7(9):e13127. doi: 10.2196/13127. [IF: 6.2, Ranked 10 out of 185 under the category of “Health Care Sciences & Services”]